Manuscripts
Showing 1596 manuscripts.
Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases.
Citation
Ian Marschner, Ph.D., Rebecca Betensky, Ph.D., Victor DeGruttola, Sc.D., Scott M. Hammer, M.D., Daniel R. Kuritzkes, M.D. Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999 Mar 01; 20(3):220-7.Year
1999
Journal
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl
Citation
Heather D. Watts, M.D., Catherine Spino, Sc.D., Larry Zaborski, M.S., David Katzenstein, M.D., Scott M. Hammer, M.D., Constance A. Benson, M.D. Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999 Apr 15; 20(5):455-62.Year
1999
Journal
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication
Citation
Abhay H. Patki, Scott F. Purvis, Ph.D., Hernan Valdez, John Spritzler, Sc.D., Elizabeth Connick, Daniel R. Kuritzkes, Harold Kessler, Lawrence Fox, Marty St. Clair, Alan Landay, Michael M. Lederman, M.D. HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication. AIDS. 1999 Jul 09; 13(10):1177-85.Year
1999
Journal
AIDS
Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol
Citation
Huldrych F. Gunthard, Andrew J. Leigh-Brown, Richard T. D'Aquila, Victoria A. Johnson, Daniel R. Kuritzkes, Douglas D. Richman, Joseph K. Wong. Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol. Virology. 1999 Jun 20; 259(1):154-65.Year
1999
Journal
Virology
Granulocyte-macrophage colony-stimulating factor: potential therapeutic, immunological and antiretroviral effects in HIV infection
Citation
Stanley C. Deresinski, M.D., F.A.C.P. Granulocyte-macrophage colony-stimulating factor: potential therapeutic, immunological and antiretroviral effects in HIV infection. AIDS. 1999 Apr 16; 13(6):633-43.Year
1999
Journal
AIDS
Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children with Human Immunodeficiency Virus Infection
Citation
Mark W. Kline, M.D., Suzette Blanchard, M.S., Ph.D., Courtney V. Fletcher, Pharm.D., Jerry L. Shenep, M.D., Ross E. McKinney, Jr., M.D., Richard Brundage, Pharm.D., Ph.D., Mary Culnane, C.R.N.P., M.S., Russell B. Van Dyke, M.D., Wayne M. Dankner, M.D., Andrea Kovacs, M.D., Jim McDowell, Seth Hetherington, M.D. Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children with Human Immunodeficiency Virus Infection. Pediatrics. 1999 Apr 01; 103(e47):1-5.Year
1999
Journal
Pediatrics
Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin For Reducing Perinatal HIV Transmission from HIV-Infected Women with Advanced HIV Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185
Citation
E. Richard Stiehm, John S. Lambert, Lynne M. Mofenson, James Bethel, Jean Whitehouse, Robert Nugent, John Moye, Mary Glen Fowler, Bonnie Mathieson, Patricia Reichelderfer, Georg J. Nemo, James Korelitz, William A. Meyer, III, Christine V. Sapan, Eleanor Jimenez, Jorge Gandia, Gwendolyn Scott, Mary Jo O'Sullivan, Andrea Kovacs, Alice Stek, William T. Shearer, Hunter Hammill. Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin For Reducing Perinatal HIV Transmission from HIV-Infected Women with Advanced HIV Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185. Journal of Infectious Diseases. 1999 Jan 01; 179(3):567-75.Year
1999
Journal
Journal of Infectious Diseases
Pharmacokinetics Of Dapsone Administered Daily And Weekly In Human Immunodeficiency Virus-Infected Children
Citation
Mirochnick M, Ellen Rae Cooper, M.P.H., M.D., McIntosh K, Xu J, Lindsey J, Jacobus D, Mofenson LM, Sullivan JL, Dankner W, Frenkel LM, Nachman S, Wara DW, Johnson D, Bonagura V, Rathore M, Coleen K. Cunningham, M.D., James McNamara, M.D. Pharmacokinetics Of Dapsone Administered Daily And Weekly In Human Immunodeficiency Virus-Infected Children. Antimicrobial Agents and Chemotherapy. 1999 Jan 01; 43(11):2586-91.Year
1999
Journal
Antimicrobial Agents and Chemotherapy
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
Citation
Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM, Cunningham B, Oleske J. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. The Journal of the American Medical Association. 1999 Jan 13; 281(2):151-157. PMID: 9917118.Year
1999
Journal
The Journal of the American Medical Association
Recent Developments In Pediatric HIV-1 Infection
Citation
Burns DN, Mofenson LM. Recent Developments In Pediatric HIV-1 Infection. Lancet. 1999 Sep 01; 354(Supp II):SII1-6.Year
1999
Journal
Lancet